Our previous studies have shown that neuronal nitric oxide synthase (nNOS) expression levels in patient biopsies significantly correlated with the disease stage, and that nNOS inhibitors may be a promising direction for melanoma treatment [9,10]. The gene discussed is NOS1; the disease is melanoma.